200 related articles for article (PubMed ID: 26851835)
1. 2-Oxo-1,2-dihydropyridinyl-3-yl amide-based GPa inhibitors: Design, synthesis and structure-activity relationship study.
Loughlin WA; Jenkins ID; Karis ND; Schweiker SS; Healy PC
Eur J Med Chem; 2016 Mar; 111():1-14. PubMed ID: 26851835
[TBL] [Abstract][Full Text] [Related]
2. Discovery of new nanomolar inhibitors of GPa: Extension of 2-oxo-1,2-dihydropyridinyl-3-yl amide-based GPa inhibitors.
Loughlin WA; Jenkins ID; Karis ND; Healy PC
Eur J Med Chem; 2017 Feb; 127():341-356. PubMed ID: 28076824
[TBL] [Abstract][Full Text] [Related]
3. Glycogen phosphorylase inhibitory effects of 2-oxo-1,2-dihydropyridin-3-yl amide derivatives.
Karis ND; Loughlin WA; Jenkins ID; Healy PC
Bioorg Med Chem; 2009 Jul; 17(13):4724-33. PubMed ID: 19443226
[TBL] [Abstract][Full Text] [Related]
4. The glycogen phosphorylase inhibitor 2-(3-benzylamino-2-oxo-1,2-dihydropyridin-1-yl)-N-(3,4-dichlorobenzyl)acetamide.
Popova I; Healy PC; Loughlin WA; Karis ND; Jenkins ID
Acta Crystallogr C; 2013 Nov; 69(Pt 11):1408-10. PubMed ID: 24192198
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of (benzimidazol-2-yl)aniline derivatives as glycogen phosphorylase inhibitors.
Galal SA; Khattab M; Andreadaki F; Chrysina ED; Praly JP; Ragab FAF; El Diwani HI
Bioorg Med Chem; 2016 Nov; 24(21):5423-5430. PubMed ID: 27624527
[TBL] [Abstract][Full Text] [Related]
6. Terpenoids. III: Synthesis and biological evaluation of 23-hydroxybetulinic acid derivatives as novel inhibitors of glycogen phosphorylase.
Zhu P; Bi Y; Xu J; Li Z; Liu J; Zhang L; Ye W; Wu X
Bioorg Med Chem Lett; 2009 Dec; 19(24):6966-9. PubMed ID: 19889536
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, screening and docking of small heterocycles as glycogen phosphorylase inhibitors.
Schweiker SS; Loughlin WA; Lohning AS; Petersson MJ; Jenkins ID
Eur J Med Chem; 2014 Sep; 84():584-94. PubMed ID: 25062009
[TBL] [Abstract][Full Text] [Related]
8. Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme.
Chen L; Li H; Liu J; Zhang L; Liu H; Jiang H
Bioorg Med Chem; 2007 Nov; 15(21):6763-74. PubMed ID: 17719791
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel 2-[2-(3-hydroxy-pyridin-2-yl)-thiazol-4-yl]-acetamide derivatives as HIF prolyl 4-hydroxylase inhibitors; SAR, synthesis and modeling evaluation.
Hong YR; Kim HT; Ro S; Cho JM; Lee SH; Kim IS; Jung YH
Bioorg Med Chem Lett; 2014 Jul; 24(14):3142-5. PubMed ID: 24894560
[TBL] [Abstract][Full Text] [Related]
10. Pentacyclic triterpenes. Part 3: Synthesis and biological evaluation of oleanolic acid derivatives as novel inhibitors of glycogen phosphorylase.
Chen J; Liu J; Zhang L; Wu G; Hua W; Wu X; Sun H
Bioorg Med Chem Lett; 2006 Jun; 16(11):2915-9. PubMed ID: 16546381
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, in vitro ADME profiling and in vivo pharmacological evaluation of novel glycogen phosphorylase inhibitors.
Miao GX; Wang YD; Yan ZW; Zhang LY
Bioorg Med Chem Lett; 2020 Jul; 30(14):127117. PubMed ID: 32527535
[TBL] [Abstract][Full Text] [Related]
12. Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition.
Goyard D; Kónya B; Chajistamatiou AS; Chrysina ED; Leroy J; Balzarin S; Tournier M; Tousch D; Petit P; Duret C; Maurel P; Somsák L; Docsa T; Gergely P; Praly JP; Azay-Milhau J; Vidal S
Eur J Med Chem; 2016 Jan; 108():444-454. PubMed ID: 26708111
[TBL] [Abstract][Full Text] [Related]
13. N-aryl 2-aryloxyacetamides as a new class of fatty acid amide hydrolase (FAAH) inhibitors.
Sunduru N; Svensson M; Cipriano M; Marwaha S; Andersson CD; Svensson R; Fowler CJ; Elofsson M
J Enzyme Inhib Med Chem; 2017 Dec; 32(1):513-521. PubMed ID: 28114819
[TBL] [Abstract][Full Text] [Related]
14. A multidisciplinary study of 3-(β-d-glucopyranosyl)-5-substituted-1,2,4-triazole derivatives as glycogen phosphorylase inhibitors: Computation, synthesis, crystallography and kinetics reveal new potent inhibitors.
Kun S; Begum J; Kyriakis E; Stamati ECV; Barkas TA; Szennyes E; Bokor É; Szabó KE; Stravodimos GA; Sipos Á; Docsa T; Gergely P; Moffatt C; Patraskaki MS; Kokolaki MC; Gkerdi A; Skamnaki VT; Leonidas DD; Somsák L; Hayes JM
Eur J Med Chem; 2018 Mar; 147():266-278. PubMed ID: 29453094
[TBL] [Abstract][Full Text] [Related]
15. Advances in glycogen phosphorylase inhibitor design.
Oikonomakos NG; Somsák L
Curr Opin Investig Drugs; 2008 Apr; 9(4):379-95. PubMed ID: 18393105
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and evaluation of highly selective pyridone-based class II MET inhibitors.
She N; Zhuo L; Jiang W; Zhu X; Wang J; Ming Z; Zhao X; Cong X; Huang W
Bioorg Med Chem Lett; 2014 Aug; 24(15):3351-5. PubMed ID: 24951334
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and evaluation of 8-amino-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one derivatives as glycogen synthase kinase-3 (GSK-3) inhibitors.
Chun K; Park JS; Lee HC; Kim YH; Ye IH; Kim KJ; Ku IW; Noh MY; Cho GW; Kim H; Kim SH; Kim J
Bioorg Med Chem Lett; 2013 Jul; 23(13):3983-7. PubMed ID: 23683591
[TBL] [Abstract][Full Text] [Related]
18. The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.
Andersen B; Westergaard N
Biochem J; 2002 Oct; 367(Pt 2):443-50. PubMed ID: 12099891
[TBL] [Abstract][Full Text] [Related]
19. Discovery and evaluation of novel benzazepinone derivatives as glycogen phosphorylase inhibitors with potent activity.
Wang Y; Yan Z; Guo Y; Zhang L
Future Med Chem; 2021 May; 13(10):897-909. PubMed ID: 33906369
[TBL] [Abstract][Full Text] [Related]
20. Ligand-based modelling followed by synthetic exploration unveil novel glycogen phosphorylase inhibitory leads.
Habash M; Taha MO
Bioorg Med Chem; 2011 Aug; 19(16):4746-71. PubMed ID: 21788139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
